Gilead bought immumedics for 21 billion for their one drug Trodelvy and it is not as good as our preliminary findings with triple test cancer findings with Leronlimab. Not to mention the other indications. Hummm….. any idea if the three fingers Nader put up are possible? In time you bet ya!